Feed REP.MC
RE

Repsol, S.A. REP.MC · BME

29.57 € +4.64% (+1.31 €)

Summary

67 / 100 · Bulios Score

What speaks for it

  • The share price is below the Bulios Fair Price.
  • Analysts expect revenue to grow by 52% this fiscal year.
  • It earns 9.1 EUR a year on every 100 EUR of invested capital.
  • It bought back its own shares for 1.49B € in the last fiscal year, 4.9% of its market value.

What to watch

  • Revenue fell by 7.5% a year over the last 3 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price 29.57 €
P/E today 8.7 28% higher
5-year average P/E 6.8
P/E today 8.7
Oil & Gas Integrated industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 8.7 EUR for 1 EUR of yearly profit. Over the last five years it was 6.8 EUR on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue grew by 11% a year over 5 years. Over the last 3 years it fell by 7.5% a year. For the next fiscal year analysts expect revenue to grow by 52%. Earnings per share fell by 18% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 EUR of revenue goes

Net profit, industry median (Oil & Gas Integrated) 7.8 EUR

Out of every 100 EUR of revenue, 5.7 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 7.0 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.

Financial health in detail

Does it pay a dividend?

Moderate, safe
Yield
3.70%
Paid out of profit
32%
Raised in a row
4 years

You receive 1.05 € per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

100% of the analysts recommend buying.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy